Indi Molecular Inc Funding & Investors
Indi Molecular, Inc. operates as a life sciences company. The Company develops protein catalyzed capture (PCC) agent technology, a process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies. Indi Molecular markets its technology throughout the United States.
indimolecular.comTotal Amount Raised: $13,300,000
Indi Molecular Inc Funding Rounds
Series A
$11,500,000
Series A Investors
M VenturesLegend CapitalSabeyAsset Management VenturesSeed
$300,000
Seed Investors
Asset Management VenturesSeed
$1,500,000
Seed Investors
InterWest Partners
Funding info provided by Diffbot.